Free shipping on all orders over $ 500

Tirbanibulin (KX2-391)

Cat. No. M2313

All AbMole products are for research use only, cannot be used for human consumption.

Tirbanibulin (KX2-391) Structure
Synonym:

KX-01

Size Price Availability Quantity
1mg USD 30 In stock
5mg USD 65 In stock
10mg USD 80 In stock
50mg USD 320 In stock
100mg USD 540 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tirbanibulin (KX2-391) is a synthetic, orally bioavailable small molecule and non-ATP competitive Src tyrosine kinase signaling inhibitor with an IC50 of average 72 nM. Tirbanibulin (KX2-391) has potential antineoplastic activity. Src kinase inhibitor KX2-391 specifically binds to the peptide substrate binding site of Src kinase. In addition, Tirbanibulin (KX2-391) also inhibits microtubule polymerization. Preclinical studies have suggested that KX2-391 is able to prevent the proliferation and metastasis of prostate cancer cell lines in mouse xenografts. 

Chemical Information
Molecular Weight 431.53
Formula C26H29N3O3
CAS Number 897016-82-9
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Anna H Dlott, et al. Tirbanibulin: Topical Treatment for Actinic Keratosis

[2] No authors listed. Am J Health Syst Pharm. Tirbanibulin

[3] Anthony Markham, et al. Tirbanibulin: First Approval

[4] Andrew Blauvelt, et al. Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

[5] No authors listed. Tirbanibulin

Related Src-bcr-Abl Products
AP24534

Ponatinib (AP24534) is a novel potent, orally available small molecule multitargeted kinase inhibitor of BCR-ABL, PDGFRα, c-Src, c-Kit, FGFR and VEGFR.

Saracatinib

Saracatinib (AZD0530) is an orally active small molecule Src inhibitor.

Bosutinib

Bosutinib (SKI-606) is a novel Bcr-Abl inhibitor with IC50 values of 0.1 to 0.3 umol/L.

Dasatinib

Dasatinib (BMS-354825) is a small molecule inhibitor of both the SRC and BCR/ABL tyrosine kinases, with IC50's for the isolated kinases of 0.55 and 3.0 nM, respectively.

DCC-2036

DCC-2036 is an ABL inhibitor with IC50 of 0.8 and 2 nM for u-ABL1native and p-ABL1native, respectively.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tirbanibulin (KX2-391), KX-01 supplier, Src-bcr-Abl, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.